LCZ696

CAS No.:936623-90-4

Other Names:LCZ696

MF:2(C24H29N5O3).2(C24H29NO5).5(H2O).6Na, 2(C24H29N5O3).2(C24H29NO5).5(H2O).6Na

Place of Origin: China (Mainland)

Type:Antibiotic and Antimicrobial Agents

Grade Standard:Medicine Grade

Purity:99%min

Product name:LCZ696

Color:White powder LCZ696

Molecular Weight:0 LCZ696

Storage:Stock at RT. LCZ696

MOQ:1 KG LCZ696

Loading port: any port in China

Supply Ability

Supply Ability:

200 Ton/Tons per Month LCZ696

Packaging & Delivery

Packaging Details

200KG/Barrel Or according customers' requirement LCZ696

Lead Time : 10-30 workdays

LCZ696 CAS 936623-90-4

Product Description

1.LCZ696 CAS 936623-90-4 Detailed description

LCZ696 is a treatment of heart failure drugs developed by Novartis Pharmaceuticals. Heart failure is a

life-threatening and degenerative disease. The patient's heart can not pump enough blood to supply the

whole body, breathing difficulties, fatigue and fluid retention Can appear slowly, and gradually increased,

significantly affect the quality of life.
LCZ696, a dual-acting angiotensin receptor enkephalinase inhibitor, has a unique mode of action that is

thought to reduce the strain of failing heart. LCZ696 enhances the body's natural defenses against heart

failure by increasing the levels of natriuretic and other endogenous vasoactive peptides and inhibiting the

renin-angiotensin-aldosterone system (RAAS). LCZ696 combines Novartis's hypertensive drug diovan

(generic name: valsartan) with the experimental drug AHU-377. AHU377 blocks the mechanisms that

threaten the two peptides responsible for lowering blood pressure, while Diovan improves vasodilation

and stimulates the body to excrete sodium and water.

English name: LCZ696
CAS number: 936623-90-4
Molecular formula: 2 (C24H29N5O3) .2 (C24H29NO5) .5 (H2O) .6Na